The company was founded in 2014 by Dr. Ralf Hilfrich (technical director) and Stefan Raupach (commercial director) with the vision to establish a new cancer screening program for the early detection of HPV-induced mouth and throat cancer. The two founders combine more than 40 years of experience in the development, manufacturing and marketing of in-vitro diagnostics. Located in Ammersbek near Hamburg, the company distributes the rapid test since 2015 to dentists, dermatologists and other specialists, who offer cancer prevention services to their patients.


HTGF and MBG Schleswig-Holstein invest into innovative diagnostic solution for the early detection of oral cancer

The biotech company Abviris Deutschland GmbH from Ammersbek near Hamburg, Germany, developed a rapid test for the early detection of mouth and throat cancer. High-Tech Gründerfonds (HTGF) and Mittelständische Beteiligungsgesellschaft Schleswig-Holstein (MBG) invest a mid six-figure amount and support therefore the…

Info & Contact

Stefan Raupach


Beimoorkamp 6
22926 Ahrensburg

In portfolio

16. Dec 2015